Perhaps it’s some morning stiffness you first notice, or some swelling in your fingers, wrists or toes. The early symptoms of ...

In patients with RA, BMI affects cardiovascular risk, differing by anti–citrullinated protein antibody (ACPA) status and ...

The global rheumatoid arthritis drugs market was valued at $57,929 million in 2019, and is projected to reach $62,935 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Alarming rise in ...

A major Medicare study shows that while long-term steroid use declines after diagnosis of late-onset rheumatoid arthritis, a ...

By pausing DMARDs, you may be ‘starting the cascade of getting the patient into trouble by interrupting therapy that’s ...

Adverse events from disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis decline by as much as 25% after the drugs are established on the market, according to data published ...

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

Female patients with rheumatoid arthritis show higher disease activity and greater functional impairment than males, despite ...

Long-term glucocorticoid (GC) use among older adults with late-onset rheumatoid arthritis (LORA) remains prevalent, despite its known adverse effects, according to study results published in ACR Open ...

Discover the early warning signs of psoriatic arthritis that could prevent permanent joint damage, plus expert advice on treatment options and daily management.

Netherlands: A new study published in Clinical Rheumatology has highlighted the risks associated with prolonged ...